Download PDF
Journal of Pediatric Biochemistry 2015; 05(02): 060-064
DOI: 10.1055/s-0035-1564576
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Inflammatory Bowel Disease and the Intestinal Microbiota

Andrew S. Day
1   Department of Paediatrics, University of Otago Christchurch, Christchurch, New Zealand
› Author Affiliations
Further Information

Publication History

17 May 2015

28 May 2015

Publication Date:
15 September 2015 (online)

    Permissions and Reprints

Abstract

Not surprisingly given the close proximity of the intestinal microflora to the intestinal mucosa, members of the intestinal flora are implicated in the development of chronic intestinal conditions known as the inflammatory bowel diseases. This group of conditions is principally composed of Crohn disease and ulcerative colitis. While perturbations in the balance of the members of the intestinal microflora are well characterized, it remains unclear if this so-called dysbiosis is critical to the development and onset of the inflammatory bowel diseases. Other evidence indicates that specific organisms may trigger or initiate inflammation. The advent of new molecular tools has advanced our understanding, but here remain many important unanswered questions.

Keywords

inflammatory bowel disease - Crohn disease - ulcerative colitis - intestinal microbiota - dysbiosis
 

  • References

  • 1 Lemberg DA, Day AS. Crohn disease and ulcerative colitis in children: an update for 2014. J Paediatr Child Health 2015; 51 (3) 266-270
    CrossrefPubMedGoogle Scholar
  • 2 Working IBD ; IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis—the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41 (1) 1-7
    CrossrefPubMedGoogle Scholar
  • 3 Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17 (1) 423-439
    CrossrefPubMedGoogle Scholar
  • 4 Phavichitr N, Cameron DJS, Catto-Smith AG. Increasing incidence of Crohn's disease in Victorian children. J Gastroenterol Hepatol 2003; 18 (3) 329-332
    CrossrefPubMedGoogle Scholar
  • 5 Schildkraut V, Alex G, Cameron DJS , et al. Sixty-year study of incidence of childhood ulcerative colitis finds eleven-fold increase beginning in 1990s. Inflamm Bowel Dis 2013; 19 (1) 1-6
    CrossrefPubMedGoogle Scholar
  • 6 Ng SC. Emerging leadership lecture: inflammatory bowel disease in Asia: emergence of a “Western” disease. J Gastroenterol Hepatol 2015; 30 (3) 440-445
    CrossrefPubMedGoogle Scholar
  • 7 Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003; 91 (441) 48-55
    PubMedGoogle Scholar
  • 8 Funkhouser LJ, Bordenstein SR. Mom knows best: the universality of maternal microbial transmission. PLoS Biol 2013; 11 (8) e1001631
    CrossrefPubMedGoogle Scholar
  • 9 Agostoni C, Kim KS. Nutrition and the microbiome 2015. Pediatr Res 2015; 77 (1–2) 113-114
    CrossrefPubMedGoogle Scholar
  • 10 Madsen KL. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse. Clin Invest Med 2001; 24 (5) 250-257
    PubMedGoogle Scholar
  • 11 Rutgeerts P, Hiele M, Geboes K , et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108 (6) 1617-1621
    CrossrefPubMedGoogle Scholar
  • 12 Rutgeerts P, Goboes K, Peeters M , et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991; 338 (8770) 771-774
    CrossrefPubMedGoogle Scholar
  • 13 D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114 (2) 262-267
    CrossrefPubMedGoogle Scholar
  • 14 Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol 2011; 8 (3) 152-168
    CrossrefPubMedGoogle Scholar
  • 15 Rehman A, Lepage P, Nolte A, Hellmig S, Schreiber S, Ott SJ. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 2010; 59 (Pt 9) 1114-1122
    CrossrefPubMedGoogle Scholar
  • 16 Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104 (34) 13780-13785
    CrossrefPubMedGoogle Scholar
  • 17 Garrett WS, Gallini CA, Yatsunenko T , et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010; 8 (3) 292-300
    CrossrefPubMedGoogle Scholar
  • 18 Kaakoush NO, Day AS, Huinao KD , et al. Microbial dysbiosis in pediatric patients with Crohn's disease. J Clin Microbiol 2012; 50 (10) 3258-3266
    CrossrefPubMedGoogle Scholar
  • 19 Kirkwood CD, Wagner J, Boniface K , et al. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm Bowel Dis 2009; 15 (11) 1643-1655
    CrossrefPubMedGoogle Scholar
  • 20 Darfeuille-Michaud A, Boudeau J, Bulois P , et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127 (2) 412-421
    CrossrefPubMedGoogle Scholar
  • 21 Carrière J, Darfeuille-Michaud A, Nguyen HT. Infectious etiopathogenesis of Crohn's disease. World J Gastroenterol 2014; 20 (34) 12102-12117
    CrossrefPubMedGoogle Scholar
  • 22 Bach H. What role does mycobacterium avium subsp. Paratuberculosis play in Crohn's disease?. Curr Infect Dis Rep 2015; 17 (2) 463
    PubMedGoogle Scholar
  • 23 Selby W, Pavli P, Crotty B , et al; Antibiotics in Crohn's Disease Study Group. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 2007; 132 (7) 2313-2319
    CrossrefPubMedGoogle Scholar
  • 24 Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 2004; 42 (6) 2766-2768
    CrossrefPubMedGoogle Scholar
  • 25 Laharie D, Asencio C, Asselineau J , et al. Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment Pharmacol Ther 2009; 30 (3) 283-293
    CrossrefPubMedGoogle Scholar
  • 26 Zhang S, Zhong B, Chao K , et al. Role of Helicobacter species in Chinese patients with inflammatory bowel disease. J Clin Microbiol 2011; 49 (5) 1987-1989
    CrossrefPubMedGoogle Scholar
  • 27 Veijola L, Nilsson I, Halme L , et al. Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease. Ann Med 2007; 39 (7) 554-560
    CrossrefPubMedGoogle Scholar
  • 28 Man SM, Zhang L, Day AS, Leach S, Mitchell H. Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter 2008; 13 (4) 234-238
    CrossrefPubMedGoogle Scholar
  • 29 Kalischuk LD, Buret AG. A role for Campylobacter jejuni-induced enteritis in inflammatory bowel disease?. Am J Physiol Gastrointest Liver Physiol 2010; 298 (1) G1-G9
    CrossrefPubMedGoogle Scholar
  • 30 Zhang L, Man SM, Day AS , et al. Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol 2009; 47 (2) 453-455
    CrossrefPubMedGoogle Scholar
  • 31 Man SM, Zhang L, Day AS, Leach ST, Lemberg DA, Mitchell H. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis 2010; 16 (6) 1008-1016
    CrossrefPubMedGoogle Scholar
  • 32 Hansen R, Mukhopadhya I, Russell RK , et al. The role of microaerophilic colonic mucosal bacteria in de novo paediatric inflammatory bowel disease. Gut 2011; 60 (Suppl. 01) A147
    PubMedGoogle Scholar
  • 33 Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, Hold GL. Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS ONE 2011; 6 (6) e21490
    CrossrefPubMedGoogle Scholar
  • 34 Macuch PJ, Tanner AC. Campylobacter species in health, gingivitis, and periodontitis. J Dent Res 2000; 79 (2) 785-792
    CrossrefPubMedGoogle Scholar
  • 35 Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Clinical manifestations of Campylobacter concisus infection in children. Pediatr Infect Dis J 2013; 32 (11) 1194-1198
    CrossrefPubMedGoogle Scholar
  • 36 Kaakoush NO, Castaño-Rodríguez N, Day AS, Lemberg DA, Leach ST, Mitchell HM. Faecal levels of zonula occludens toxin in paediatric patients with Crohn's disease and their association with the intestinal microbiota. J Med Microbiol 2015; 64 (Pt 3) 303-306
    CrossrefPubMedGoogle Scholar
  • 37 Kaakoush NO, Castaño-Rodríguez N, Day AS, Lemberg DA, Leach ST, Mitchell HM. Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohn's disease and their association with the intestinal microbiota. J Med Microbiol 2014; 63 (Pt 1) 99-105
    CrossrefPubMedGoogle Scholar
  • 38 Man SM, Kaakoush NO, Leach ST , et al. Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis 2010; 202 (12) 1855-1865
    CrossrefPubMedGoogle Scholar
  • 39 Critch J, Day AS, Otley AR, King-Moore C, Teitelbaum JE, Shashidhar H . NASPGHAN IBD Committee. Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2012; 54 (2) 298-305
    CrossrefPubMedGoogle Scholar
  • 40 Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease. Aliment Pharmacol Ther 2008; 28 (6) 724-733
    CrossrefPubMedGoogle Scholar
  • 41 Lionetti P, Callegari ML, Ferrari S , et al. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr 2005; 29 (4, Suppl): S173-S175 , discussion S175–S178, S184–S188
    CrossrefPubMedGoogle Scholar
  • 42 Kaakoush NO, Day AS, Leach ST, Lemberg DA, Nielsen S, Mitchell HM. Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease. Clin Transl Gastroenterol 2015; 6: e71
    CrossrefPubMedGoogle Scholar